Claudia Cisneros v. Urovant Sciences Ltd.: Complaint

Complaint alleging the defendants made “untrue statements of fact and/or omitted material facts” in Claudia Cisneros v. Urovant Sciences Ltd., described as a Bermuda-domiciled “clinical-stage biopharmaceutical company” whose shares are listed on NASDAQ; James Robinson and whose parent is domiciled in the Cayman Islands; Myrtle Potter, James Hindman, SEF P Kurstjens, Pierre Legault, and Shigeyuki Nishinaka at the U. S. District Court for the Southern District of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 14

Date: January 27, 2021

Defendants/Respondents: Urovant Sciences Ltd., James Robinson, Myrtle Potter, James Hindman, SEF P Kurstjens, Pierre Legault, Shigeyuki Nishinaka

Plaintiffs/Applicants Attorneys: Moore Kuehn, Justin Kuehn

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities

Plaintiffs/Applicants: Claudia Cisneros

Topics

Keywords

Claudia Cisneros James Hindman James Robinson Myrtle Potter Pierre Legault

SEF P Kurstjens Shigeyuki Nishinaka Sumitovant Biopharma Ltd. Titan Ltd. Urovant Sciences Ltd.

[ 5 more... ] [ top 5 ]

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.